ANGLOLAB S.A.
ANGLOLAB S.A. is a BUPA-owned Peruvian clinical laboratory network founded in 1994, providing accredited diagnostic testing across biochemistry, immunology, hematology, microbiology, molecular biology, pathology, and blood banking to patients, physicians, and corporate clients via embedded operations in 15+ partner clinics across Lima, Arequipa, and Cusco.
- Company typePrivate
- Founded1994
- HeadquartersSan Isidro, Peru
- Headcount11–50
- GTM typeB2B
- OfferingServices
What ANGLOLAB S.A. does
ANGLOLAB S.A. is a Peruvian clinical laboratory network founded in 1994 by three physicians — alumni of Universidad Peruana Cayetano Heredia — at the request of Clínica Angloamericana, which remains its founding partner and largest distribution channel. The company provides diagnostic testing across biochemistry, immunology, hematology, microbiology, molecular biology, pathology, and blood banking, using European-manufactured automated analyzers supported by participation in international external quality assessment programs (CAP and Bio-Rad EQAS across 15+ disciplines). Anglolab holds an unusual stacked regulatory profile for Peru: ISO-NTP 15189:2014 accreditation (INACAL, April 2023, Clinical Biochemistry), four consecutive Joint Commission International accreditation cycles (2013, 2016, 2019, 2022), and DAIDS GCLP certification for participation in NIAID-sponsored clinical trials since 2002 (monitored by pSMILE at Johns Hopkins and audited annually by PPD).
Operationally, Anglolab runs an embedded laboratory model inside 15+ partner clinics and hospitals across Lima, Arequipa, and Cusco, with separate branded patient, physician, and corporate web portals. Services are priced per individual test (S/ 16.31 to S/ 384.02 including IGV) on a pay-as-you-go basis, with quote-based corporate accounts. Revenue is therefore transactional and volume-driven rather than contract-driven. The company employs 260+ staff including pathologists, technologists, technicians, biologists, and administrative personnel.
Since 2013 Anglolab has been owned by UK-based BUPA (acquired via the Chilean Cruz Blanca group in the same year), operating as a subsidiary within BUPA's Latin American healthcare portfolio. Strategic direction is therefore influenced by a global healthcare conglomerate rather than its physician-founders, though specific equity, board, or BUPA strategic integration details are not publicly disclosed.
ANGLOLAB S.A. firmographics
Firmographics- Name
- ANGLOLAB S.A.
- Legal name
- ANGLOLAB S.A.
- Website
- https://anglolab.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ANGLOLAB S.A. is a BUPA-owned Peruvian clinical laboratory network founded in 1994, providing accredited diagnostic testing across biochemistry, immunology, hematology, microbiology, molecular biology, pathology, and blood banking to patients, physicians, and corporate clients via embedded operations in 15+ partner clinics across Lima, Arequipa, and Cusco.
- Ownership category
- akta.pro rank
ANGLOLAB S.A. industry classification
Industry- Product category
- Clinical Laboratory Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical Research & Trial Central Laboratories (HLAFAMAL)
- akta.pro secondary industry
- Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza) (HLAJAIAD)
Keywords
Where ANGLOLAB S.A. is headquartered
LocationHeadquarters
- HQ city
- San Isidro
- HQ country
- Peru
- HQ region
- Latin America
Offices15 records
Markets served
ANGLOLAB S.A. business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Clinical Laboratory Testing Services: Anglolab generates revenue through individual clinical laboratory tests and analyses performed for patients, physicians, and corporate clients. Tests are priced individually with variation by location; prices include IGV (Peruvian sales tax).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Individual test pricing ranging from S/ 16.31 to S/ 384.02 |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
ANGLOLAB S.A. product offering
Product offeringCore offering
Anglolab S.A. is a Peruvian clinical laboratory network that performs diagnostic laboratory testing across Biochemistry, Immunology, Hematology, Microbiology, Molecular Biology, Pathology, and Blood Banking disciplines. The company delivers its services through an embedded model within 15+ partner clinics and hospitals in Lima, Arequipa, and Cusco, and also offers blood donation services and dedicated web portals (patient, physician, corporate) for accessing test results.
Product overview
ANGLOLAB S.A. is a clinical laboratory network offering a unified portfolio of diagnostic laboratory services delivered through multiple channels: in-person sample collection at affiliated clinic locations, online result access via patient/physician/corporate portals, and blood donation services. The core offering consists of clinical analysis across biochemistry, immunology, hematology, microbiology, molecular biology, pathology, and blood banking disciplines, with testing prices publicly available on the website.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Laboratory Testing Services (Análisis Clínicos) Comprehensive clinical laboratory testing covering Biochemistry, Immunology, Hematology, Microbiology, Molecular Biology, Pathology, and Blood Banking disciplines. Services are delivered to patients, referring physicians, partner clinics, and corporate clients; tests are individually priced and publicly listed on the Anglolab website.
- Blood Donation Services (Donación de Sangre) Blood donation services including donor screening, blood typing, hemoglobin testing, and infectious disease screening for Hepatitis B/C, HIV, Syphilis, Chagas disease, and HTLV I-II. Targeted at healthy adult volunteers and supporting partner clinics' transfusion needs.
- Patient Portal (Portal del Paciente) Authenticated web portal for individual patients to access and view their laboratory test results, manage appointments, and interact with Anglolab's healthcare services.
- Physician Portal (Portal del Médico) Authenticated web portal for registered physicians to access their patients' laboratory results, view diagnostic information, and manage clinical workflows with Anglolab.
- Corporate/Enterprise Portal (Portal del Cliente/Empresa) Dedicated web portal for corporate clients and companies to manage employee laboratory services, access reports, and coordinate occupational health and corporate wellness programs with Anglolab.
Quantifiable outcome
- JCI accreditation maintained for 4 consecutive cycles (2013, 2016, 2019, 2022)
- +2 more outcomes
Companies that use ANGLOLAB S.A.
Customer profileNamed customers12 records
Segments4 records
Ideal customer profiles3 records
ANGLOLAB S.A. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
ANGLOLAB S.A. partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- IntegraMédica Perú S.A.C.coreShared services partner - processes candidate data from personnel selection procedures. Also operates as a co-located clinic partner where Anglolab provides laboratory services. Contact for data protection: [email protected]
- Clínica AngloamericanacoreFounding partner and primary client since 1994. Clínica Angloamericana is a leading private healthcare institution in Lima. Anglolab was established to serve their laboratory needs. JCI accredited since 2013.
- Partner Healthcare Clinicscore15+ partner clinics including Clínica Padre Luis Tezza, Clínica Stella Maris, Clínica Monterrico, Clínica Miraflores, Concebir, Inmater, and Clínica San Juan de Dios in Arequipa and Cusco where Anglolab provides embedded laboratory services.
- pSMILE (Johns Hopkins University)minorPatient Safety Monitoring in International Laboratories - a contractual resource at Johns Hopkins University designed to evaluate and develop laboratory capacity for NIH-DAIDS clinical trials.
- PPD (Pharmaceutical Product Development)minorConducts annual GCLP audits for Anglolab's clinical trial laboratory operations supporting DAIDS-sponsored studies.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
ANGLOLAB S.A. competitors and assessment
Company assessmentDirect peers
- Eurofins Scientific: Global laboratory testing services group operating across clinical, pharmaceutical, food, and environmental testing. Comparable to Anglolab at the laboratory testing methodology and accreditation level; broader in scope but overlapping in clinical diagnostics operations and external quality participation.
- Synlab: Europe's largest clinical laboratory services provider operating an accredited lab network across multiple countries. Directly comparable to Anglolab in core business: routine and specialty clinical diagnostic testing with international quality accreditation and embedded collection networks serving patients, physicians, and corporate clients.
- Cerba HealthCare: International clinical reference laboratory and diagnostics provider. Comparable to Anglolab in reference-laboratory positioning, specialty testing across multiple disciplines, and central laboratory services for clinical trials across multiple geographies.
- Unilabs: European clinical laboratory network offering medical diagnostics across multiple specialties. Comparable to Anglolab as a multi-country clinical lab chain with strong reference-laboratory positioning, international quality accreditation, and embedded physician and partner relationships.
Broad incumbents
- Quest Diagnostics: Largest US clinical laboratory services company with international reach. Comparable to Anglolab in clinical laboratory diagnostics operations, CAP-accredited quality participation, and routine plus specialty testing; broader incumbency and geographic reach distinguish the two.
- Sonic Healthcare: Global medical diagnostics company operating laboratory and radiology services across Australia, Europe, and North America. Comparable to Anglolab in clinical laboratory testing focus with international quality accreditation and embedded provider relationships.
- Laboratory Corporation of America (Labcorp): Major US-based clinical laboratory network with global operations in routine and specialty diagnostics, clinical trial central lab services, and physician/patient portals. Comparable to Anglolab as broad incumbent in clinical lab testing with established international accreditation.
Regional players
- Grupo Fleury: Brazilian medical diagnostics company offering clinical laboratory, imaging, and pathology services. Comparable to Anglolab in clinical diagnostics business model serving patients, physicians, and corporate clients across multiple Brazilian markets with similar accreditation emphasis.
- Dasa: Brazil's largest medical diagnostics company providing clinical laboratory, imaging, and genomic testing services. Comparable to Anglolab as the LATAM leader in clinical diagnostics with multi-modality offerings, embedded hospital partnerships, and broad test menu across Brazil.
- Auna: Peruvian healthcare network providing oncology, hospital, and diagnostic services with a significant footprint in Lima and other Peruvian cities. Comparable as a Peru-headquartered healthcare organization operating across the same geography as Anglolab, with overlapping diagnostic capabilities serving similar referring physicians and patient populations.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
ANGLOLAB S.A. social profiles
Digital presenceANGLOLAB S.A. compliance and trust
Trust signalCompliance4 records
ANGLOLAB S.A. financial estimates
Financial estimateRevenue estimate
Valuation estimate
ANGLOLAB S.A. leadership team
Management profileNumber of profiles
ANGLOLAB S.A. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ANGLOLAB S.A. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ANGLOLAB S.A.
What does ANGLOLAB S.A. do?
Anglolab S.A. is a Peruvian clinical laboratory network that performs diagnostic laboratory testing across Biochemistry, Immunology, Hematology, Microbiology, Molecular Biology, Pathology, and Blood Banking disciplines. The company delivers its services through an embedded model within 15+ partner clinics and hospitals in Lima, Arequipa, and Cusco, and also offers blood donation services and dedicated web portals (patient, physician, corporate) for accessing test results.
Is ANGLOLAB S.A. a public or private company?
ANGLOLAB S.A. is a private company. It is classified as corporate owned and is currently operating.
When was ANGLOLAB S.A. founded?
ANGLOLAB S.A. was founded in 1994. It employs 11 to 50 people.
Where is ANGLOLAB S.A. based?
ANGLOLAB S.A. is headquartered in San Isidro, Peru, in the Latin America region.
How does ANGLOLAB S.A. make money?
One revenue line is on record: clinical Laboratory Testing Services.
Who are ANGLOLAB S.A.'s main competitors?
Direct peers on record are Eurofins Scientific, Synlab, Cerba HealthCare and Unilabs. Broad incumbents are Quest Diagnostics, Sonic Healthcare and Laboratory Corporation of America (Labcorp). Regional players are Grupo Fleury, Dasa and Auna.
Does ANGLOLAB S.A. have an API?
No public API is recorded for ANGLOLAB S.A..
What industry is ANGLOLAB S.A. in?
ANGLOLAB S.A.'s product category is Clinical Laboratory Services. Its primary akta.pro industry code is HLAFAMAL, Clinical Research & Trial Central Laboratories, with a secondary code of HLAJAIAD, Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza). Its NAICS code is 621511 and its SIC code is 8071.